| abstract |
FIELD: medicine.SUBSTANCE: present invention relates to the field of medicine, in particular to the treatment of skin diseases; it is intended for the use of a probiotic composition containing therapeutically effective amount ofBifidobacterium animalissubspecieslactis(B. lactis),Bifidobacterium longumandLactobacillus caseifor the treatment and/or prevention of atopic dermatitis, wherein the concentration ofB. longumis 30-40% relatively to the total concentration of microorganisms present in the composition, the concentration ofB. lactisis 30-40% relatively to the total concentration of microorganisms present in the composition, and the concentration ofL. caseiis 25-35% relatively to the total concentration of microorganisms present in the composition.EFFECT: technical result of the present invention is obtaining a probiotic composition that modifies the intestinal microbiota of an individual suffering from atopic dermatitis, together with the usual treatment, unexpectedly provides remission and/or improvement in the development of atopic dermatitis outbreaks in an individual.12 cl, 7 tbl, 11 dwg, 3 ex |